Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes

Genome Institute of Singapore, Genome #02-01, Singapore.
BMC Cancer (Impact Factor: 3.36). 02/2007; 7(1):109. DOI: 10.1186/1471-2407-7-109
Source: PubMed


Melanoma is the major cause of skin cancer deaths and melanoma incidence doubles every 10 to 20 years. However, little is known about melanoma pathway aberrations. Here we applied the robust Gene Identification Signature Paired End diTag (GIS-PET) approach to investigate the melanoma transcriptome and characterize the global pathway aberrations.
GIS-PET technology directly links 5' mRNA signatures with their corresponding 3' signatures to generate, and then concatenate, PETs for efficient sequencing. We annotated PETs to pathways of KEGG database and compared the murine B16F1 melanoma transcriptome with three non-melanoma murine transcriptomes (Melan-a2 melanocytes, E14 embryonic stem cells, and E17.5 embryo). Gene expression levels as represented by PET counts were compared across melanoma and melanocyte libraries to identify the most significantly altered pathways and investigate the expression levels of crucial cancer genes.
Melanin biosynthesis genes were solely expressed in the cells of melanocytic origin, indicating the feasibility of using the PET approach for transcriptome comparison. The most significantly altered pathways were metabolic pathways, including upregulated pathways: purine metabolism, aminophosphonate metabolism, tyrosine metabolism, selenoamino acid metabolism, galactose utilization, nitrobenzene degradation, and bisphenol A degradation; and downregulated pathways: oxidative phosphorylation, ATPase synthesis, TCA cycle, pyruvate metabolism, and glutathione metabolism. The downregulated pathways concurrently indicated a slowdown of mitochondrial activities. Mitochondrial permeability was also significantly altered, as indicated by transcriptional activation of ATP/ADP, citrate/malate, Mg++, fatty acid and amino acid transporters, and transcriptional repression of zinc and metal ion transporters. Upregulation of cell cycle progression, MAPK, and PI3K/Akt pathways were more limited to certain region(s) of the pathway. Expression levels of c-Myc and Trp53 were also higher in melanoma. Moreover, transcriptional variants resulted from alternative transcription start sites or alternative polyadenylation sites were found in Ras and genes encoding adhesion or cytoskeleton proteins such as integrin, beta-catenin, alpha-catenin, and actin.
The highly correlated results unmistakably point to a systematic downregulation of mitochondrial activities, which we hypothesize aims to downgrade the mitochondria-mediated apoptosis and the dependency of cancer cells on angiogenesis. Our results also demonstrate the advantage of using the PET approach in conjunction with KEGG database for systematic pathway analysis.

Download full-text


Available from: Kuo Ping Chiu, Oct 09, 2014
  • Source
    • "Several available large-scale ''survey'' methodologies, including CAGE (Shiraki et al. 2003), TEC-RED (Hwang et al. 2004), GIS- PET (Chiu et al. 2007; Ng et al. 2007), and MS-PET (Ng et al. 2006), may be used to aid defining transcript structures and boundaries. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although a highly accurate sequence of the Caenorhabditis elegans genome has been available for 10 years, the exact transcript structures of many of its protein-coding genes remain unsettled. Approximately two-thirds of the ORFeome has been verified reactively by amplifying and cloning computationally predicted transcript models; still a full third of the ORFeome remains experimentally unverified. To fully identify the protein-coding potential of the worm genome including transcripts that may not satisfy existing heuristics for gene prediction, we developed a computational and experimental platform adapting rapid amplification of cDNA ends (RACE) for large-scale structural transcript annotation. We interrogated 2000 unverified protein-coding genes using this platform. We obtained RACE data for approximately two-thirds of the examined transcripts and reconstructed ORF and transcript models for close to 1000 of these. We defined untranslated regions, identified new exons, and redefined previously annotated exons. Our results show that as much as 20% of the C. elegans genome may be incorrectly annotated. Many annotation errors could be corrected proactively with our large-scale RACE platform.
    Genome Research 10/2009; 19(12):2334-42. DOI:10.1101/gr.098640.109 · 14.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Schizophrenia (SCZ) is a common, disabling mental illness with high heritability but complex, poorly understood genetic etiology. As the first phase of a genomic convergence analysis of SCZ, we generated 16.7 billion nucleotides of short read, shotgun sequences of cDNA from post-mortem cerebellar cortices of 14 patients and six, matched controls. A rigorous analysis pipeline was developed for analysis of digital gene expression studies. Sequences aligned to approximately 33,200 transcripts in each sample, with average coverage of 450 reads per gene. Following adjustments for confounding clinical, sample and experimental sources of variation, 215 genes differed significantly in expression between cases and controls. Golgi apparatus, vesicular transport, membrane association, Zinc binding and regulation of transcription were over-represented among differentially expressed genes. Twenty three genes with altered expression and involvement in presynaptic vesicular transport, Golgi function and GABAergic neurotransmission define a unifying molecular hypothesis for dysfunction in cerebellar cortex in SCZ.
    PLoS ONE 02/2008; 3(11):e3625. DOI:10.1371/journal.pone.0003625 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genomics is becoming the integral part of Pharmacogenomics, and the Paired-End diTag (PET) technology is creating a new paradigm in Genomics. The PET technology directly links the 5′ terminal tags of cDNAs or genomic sequences with their corresponding 3′ terminal tags to form PET ditags and concatenates them for efficient sequencing. The GIS (Gene Identification Signature)-PET analysis was developed for studying transcriptomes and pathway aberrations. It can precisely demarcate the alternative transcription start site (TSS) and the alternative polyadenylation site (PAS). The paired-end nature makes the identification of fusion genes, fusion transcripts, and pseudogenes very straightforward. Additionally, PET-associated genes can be correlated to pathway database to systematically reveal global pathway aberrations. Changes in metabolic and signal transduction pathways can be compared across different cell types. Later, the ChIP (Chromatin immunoprecipitation)-PET analysis was developed. This approach facilitates genome-wide mapping of transcription factor binding sites (TFBSs), as shown in the studies of p53, c-Myc, estrogen receptor, Oct4/ Nanog/Sox2, STAT1, NFκB. In addition, study of trimethylations of lysine4 and lysine27 in H3 histone protein demonstrated the capability of ChIP-PET for genome-wide mapping of epigenetic modifications. Integration of all these PET data would produce a comprehensive picture of genetic and epigenetic cis-acting elements, gene expression and regulation, and pathway activities; and data can be analyzed and compared at molecular, gene, and pathway levels. This article reviews the advancement of the PET technology and discusses its potential applications in Pharmacogenomics.
    Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics) 03/2008; 6(1):23-32. DOI:10.2174/187569208784017539
Show more